New technology for delivering RNA to the brain
Precision RNA delivery technology to unlock new potentials in CNS biology
This study is working on a new way to deliver RNA directly to the brain and nervous system, aiming to target the right cells safely and effectively, which could help improve treatments for conditions affecting these areas.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m Agrilife Research NIH-funded |
| Lab location | 1 site (College Station, UNITED STATES) |
| Project ID | NIH-11029063 on NIH RePORTER |
What this research studies
This research focuses on developing a new platform for delivering RNA specifically to the central nervous system (CNS). It aims to create a system that can efficiently target specific cells while minimizing any harm to them. The approach involves engineering special capsids that can release RNA once inside the cells and modifying their surfaces to ensure they enter the right cells. The effectiveness of this technology will be tested in living organisms to ensure it works better than existing methods without causing cellular stress.
Who could benefit from this research
Good fit: Ideal candidates for this research would be individuals with neurological disorders that could benefit from targeted RNA therapies.
Not a fit: Patients with conditions unrelated to the central nervous system may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for neurological conditions by allowing precise control over gene expression in the brain.
How similar studies have performed: Previous research has shown promise in RNA delivery technologies, but this approach aims to address specific limitations that have not yet been fully explored.
Where this research is happening
College Station, UNITED STATES
- Texas A&m Agrilife Research — College Station, United States (Active)
Researchers
- Principal investigator: Pellois, Jean-Philippe — Texas A&m Agrilife Research
- Study coordinator: Pellois, Jean-Philippe
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.